M&A Deal Summary

SynerLab Acquires Sophartex S.A.

On April 27, 2004, SynerLab acquired life science company Sophartex S.A. from Recordati for 17M EUR

Acquisition Highlights
  • This is SynerLab’s 1st transaction in the Life Science sector.
  • This is SynerLab’s largest (disclosed) transaction.
  • This is SynerLab’s 1st transaction in France.

M&A Deal Summary
Date 2004-04-27
Target Sophartex S.A.
Sector Life Science
Buyer(s) SynerLab
Sellers(s) Recordati
Deal Type Divestiture
Deal Value 17M EUR

Target

Sophartex S.A.

Vernouillet, France
Sophartex S.A. is a manufacturing business dedicated to the production of finished pharmaceutical dosage forms mainly for third parties. The company offers fluid bed granulation production and blisters, alu-alu strip, and sachets packaging services.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SynerLab

Entzheim, France
Category Company
Founded 2001
Sector Life Science
DESCRIPTION

SynerLab is a European pharmaceutical contract development and manufacturing organization (CDMO). SynerLab develops, manufactures, and packages drugs in various forms (solid, liquid…) on value-adding niches, specialized in small and medium-sized batches. SynerLab was founded in 2001 and is based in Entzheim, France.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 1
Country (France) 1 of 1
Year (2004) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-20 Alcala Farma SL

Correos, Spain

Alcala Farma SL is a manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and OTC products.

Buy -

Seller(S) 1

SELLER

Recordati

Milan, Italy
Category Company
Founded 1926
Sector Medical Products
Employees4,455
Revenue 2.1B EUR (2023)
DESCRIPTION

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (France) 1 of 1
Year (2004) 1 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2000-04-26 Bouchara-Recordati S.a.s.

Levallois Perret, France

Bouchara-Recordati S.a.s. offers prescription and non-prescription pharmaceutical products. Its product portfolio includes proprietary drugs and branded generics in the cough & cold, respiratory, antiinfective and antibiotic therapeutic areas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2004-06-01 Polfa Kutno S.A.

Kutno, Poland

Polfa Kutno, S.A. is a producer and marketer of prescription medicines and Over The Counter (OTC) drugs.

Sell -
Mergr

Product

Company

Legal